PSEUDOVITELLIFORM MACULOPATHY SECONDARY TO BRAF AND MEK INHIBITORS IN A PATIENT WITH METASTASIC MELANOMA

被引：0
|
作者：
Alba-Linero, C. [1 ]
Rocha De Lossada, C. [1 ]
Delgado-Fernandez, A. S. [1 ]
Jodar-Marquez, M. [1 ]
Calvo De Mora, M. Rodriguez [1 ]
Berciano-Guerrero, M. A. [2 ]
机构：
[1] Hosp Reg Malaga, Plaza Hosp Civil, Ophthalmol Dept, Malaga 29009, Spain
[2] Hosp Reg Malaga, Oncol Dept, Malaga, Spain
来源：
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS | 2019年 / 33卷 / 05期
关键词：
neuroepithelial detachment; metastasic melanoma; BRAF inhibitors; MEK inhibitors; pseudovitelliform;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1497 / 1500
页数：4
相关论文
共 50 条
  • [21] Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors
    Dolinsek, Tanja
    Prosen, Lara
    Cemazar, Maja
    Potocnik, Tjasa
    Sersa, Gregor
    RADIOLOGY AND ONCOLOGY, 2016, 50 (03) : 274 - 279
  • [22] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    Aya, F.
    Fernandez-Martinez, A.
    Gaba, L.
    Victoria, I.
    Tosca, M.
    Pineda, E.
    Gascon, P.
    Prat, A.
    Arance, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (01) : 119 - 124
  • [23] Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in Melanoma
    Pisarevsky, Evgeni
    Blau, Rachel
    Epshtein, Yana
    Ben-Shushan, Dikla
    Eldar-Boock, Anat
    Tiram, Galia
    Koshrovski-Michael, Shani
    Scomparin, Anna
    Pozzi, Sabina
    Krivitsky, Adva
    Shenbach-Koltin, Gal
    Yeini, Eilam
    Fridrich, Lidar
    White, Richard
    Satchi-Fainaro, Ronit
    ADVANCED THERAPEUTICS, 2020, 3 (08)
  • [24] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    F. Aya
    A. Fernandez-Martinez
    L. Gaba
    I. Victoria
    M. Tosca
    E. Pineda
    P. Gascon
    A. Prat
    A. Arance
    Clinical and Translational Oncology, 2017, 19 : 119 - 124
  • [25] BRAF inhibitors: resistance and the promise of combination treatments for melanoma
    Griffin, Merope
    Scotto, Daniele
    Josephs, Debra H.
    Mele, Silvia
    Crescioli, Silvia
    Bax, Heather J.
    Pellizzari, Giulia
    Wynne, Matthew D.
    Nakamura, Mano
    Hoffmann, Ricarda M.
    Ilieva, Kristina M.
    Cheung, Anthony
    Spicer, James F.
    Papa, Sophie
    Lacy, Katie E.
    Karagiannis, Sophia N.
    ONCOTARGET, 2017, 8 (44) : 78174 - 78192
  • [26] Clinical Implications of Acquired BRAF Inhibitors Resistance in Melanoma
    Savoia, Paola
    Zavattaro, Elisa
    Cremona, Ottavio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 15
  • [27] Upfront BRAF/MEK inhibitors for treatment of high-grade glioma: A case report and review of the literature
    Arbour, Gabrielle
    Ellezam, Benjamin
    Weil, Alexander G.
    Cayrol, Romain
    Vanan, Magimairajan Issai
    Coltin, Hallie
    Larouche, Valerie
    Erker, Craig
    Jabado, Nada
    Perreault, Sebastien
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [28] Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma
    Fattore, Luigi
    Malpicci, Debora
    Marra, Emanuele
    Belleudi, Francesca
    Noto, Alessia
    De Vitis, Claudia
    Pisanu, Maria Elena
    Coluccia, Pierpaolo
    Camerlingo, Rosa
    Roscilli, Giuseppe
    Ribas, Antoni
    Di Napoli, Arianna
    Torrisi, Maria Rosaria
    Aurisicchio, Luigi
    Ascierto, Paolo Antonio
    Mancini, Rita
    Ciliberto, Gennaro
    ONCOTARGET, 2015, 6 (28) : 24823 - 24841
  • [29] MEK inhibitors for the treatment of immunotherapy-resistant, AGK-BRAF fusion advanced acral melanoma: a case report and literature review
    Zhang, Yanling
    Zhang, Xifeng
    Shao, Weikang
    Gao, Ji
    Xiang, Mei
    Wang, Yan
    Liu, Mengmeng
    Zhang, Weizhen
    Liang, Xianbin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (04)
  • [30] Global trends and emerging insights in BRAF and MEK inhibitor resistance in melanoma: a bibliometric analysis
    Bai, Jianhao
    Wan, Zhongqi
    Zhou, Wanru
    Wang, Lijun
    Lou, Wei
    Zhang, Yao
    Jin, Haiying
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2025, 12
12345